Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zhong Zhang & Hai-Jun Zhang. (2021) Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential. Expert Opinion on Therapeutic Targets 25:12, pages 1077-1093.
Read now
Read now
Articles from other publishers (6)
Xudong Ao, Chao Luo, Mengni Zhang, Lisha Liu & Shunlin Peng. (2023) The efficacy of natural products for the treatment of nasopharyngeal carcinoma. Chemical Biology & Drug Design 103:1.
Crossref
Crossref
Yi Lu, Qiulan Luo, Xiaobin Jia, James P. Tam, Huan Yang, Yuping Shen & Xin Li. (2023) Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii Folium: Integration of herbal medicine, enzyme engineering, and nanotechnology. Journal of Pharmaceutical Analysis 13:3, pages 239-254.
Crossref
Crossref
Lizhen Chen, Dayun Yu, Shuang Ling & Jin-Wen Xu. (2022) Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Shan Lu, Kang Zou, Biying Guo, Jianjun Pei, Zhenzhong Wang, Wei Xiao & Linguo Zhao. (2022) One-step purification and immobilization of thermostable β-glucosidase on Na-Y zeolite based on the linker and its application in the efficient production of baohuoside I from icariin. Bioorganic Chemistry 121, pages 105690.
Crossref
Crossref
Yanyi Xiao, Yilong Liu, Zhiwei Gao, Xian Li, Min Weng, Chenghao Shi, Cheng Wang & Linxiao Sun. (2021) Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling. Aging 13:22, pages 24753-24767.
Crossref
Crossref
Fei Xu, Qiaolan Wu, Lei Li, Jie Gong, Ran Huo & Wenqiang Cui. (2021) Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers. Frontiers in Pharmacology 12.
Crossref
Crossref